- Home
- DYN vs PLNT Comparison
DYN vs PLNT Comparison
Compare DYN & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | PLNT |
|---|---|---|
| Founded | 1984 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 4.2B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DYN | PLNT |
|---|---|---|
| Price | $23.85 | $54.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $37.00 | ★ $107.46 |
| AVG Volume (30 Days) | ★ 2.4M | 1.6M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,324,144,000.00 |
| Revenue This Year | N/A | $19.22 |
| Revenue Next Year | N/A | $11.66 |
| P/E Ratio | ★ N/A | $38.47 |
| Revenue Growth | N/A | ★ 12.06 |
| 52 Week Low | $8.88 | $37.03 |
| 52 Week High | $25.00 | $114.47 |
Technical Indicators
Market Signals| Indicator | DYN | PLNT |
|---|---|---|
| Relative Strength Index (RSI) | 63.47 | 58.94 |
| Support Level | $16.47 | $49.36 |
| Resistance Level | $24.52 | $75.96 |
| Average True Range (ATR) | 1.40 | 1.57 |
| MACD | -0.06 | 0.35 |
| Stochastic Oscillator | 74.38 | 74.86 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.